Company / Assets per Share
KalVista Pharmaceuticals, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$5.90
FY2025
5-year range
$4.74 / $15.24
FY2021-FY2025
Trend
+24.4%
vs FY2024
Sector context
#139 of 210
Health Care
What the data says
At $5.90, KalVista Pharmaceuticals, Inc.'s assets per share ranks #139 of 210 in the Health Care sector. Assets per Share returned to growth in FY2025 after 3 years of decline, reaching $5.90.
Based on SEC 10-K filings.
5.90 in FY2025 with a 5-year CAGR of +1.9%.
Improved from $4.98 to $5.90 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -10.9%
- 5-Year CAGR
- +1.9%
- 10-Year CAGR
- -
Sector benchmark
#139 of 210 in Health CareTop 66% of 210This company $5.90 Sector average $296.79
▼
-98.0% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 24.4% year-over-year.
- Ranks #139 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
- Lowest assets per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.90 | +24.4% |
| FY2024 | $4.74 | -4.8% |
| FY2023 | $4.98 | -40.3% |
| FY2022 | $8.35 | -45.2% |
| FY2021 | $15.24 | +184.6% |
| FY2020 | $5.36 | -51.0% |
| FY2019 | $10.94 | +73.1% |
| FY2018 | $6.32 | +89.9% |
| FY2017 | $3.33 | -37.5% |
| FY2016 | $5.33 | -97.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026